WST Jun 2023 280.000 put
| Previous close | 2.3000 |
| Open | 2.3000 |
| Bid | 0.0000 |
| Ask | 4.8000 |
| Strike | 280.00 |
| Expiry date | 2023-06-16 |
| Day's range | 2.3000 - 2.3000 |
| Contract range | N/A |
| Volume | |
| Open interest | 3 |
ZacksHere's Why You Should Retain Glaukos (GKOS) in Your Portfolio
Glaukos (GKOS) continues to benefit from a robust product portfolio and favorable clinical trial results.
Simply Wall St.Is West Pharmaceutical Services, Inc.'s (NYSE:WST) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
West Pharmaceutical Services' (NYSE:WST) stock is up by a considerable 35% over the past three months. Since the market...
ZacksWest Pharmaceutical (WST) Q1 Earnings Beat, Order Book Strong
West Pharmaceutical's (WST) first-quarter results reflect a sustained recovery in non-COVID-19 demand amid dismal overall performance.
ZacksWest Pharmaceutical Services (WST) Tops Q1 Earnings and Revenue Estimates
West Pharmaceutical (WST) delivered earnings and revenue surprises of 18.56% and 2.78%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
ZacksZacks Industry Outlook Highlights West Pharmaceutical Services, The Cooper Companies and Henry Schein
West Pharmaceutical Services, The Cooper Companies and Henry Schein have been highlighted in this Industry Outlook article.
ZacksWest Pharmaceutical Services (WST) is a Great Momentum Stock: Should You Buy?
Does West Pharmaceutical Services (WST) have what it takes to be a top stock pick for momentum investors? Let's find out.
ZacksMedical Device Stocks' Q1 Earnings on Apr 27: WST, DXCM, BAX
Medical Device companies' Q1 results are likely to reflect strength in customer demand. Let's see how WST, DXCM and BAX are placed ahead of their earnings releases.
Zacks3 Dental Supplies Stocks to Buy as Industry Prospects Recover
Here, we discuss three stocks from the Dental Supplies industry that are likely to create wealth for investors. These include WST, COO and HSIC.
ZacksHenry Schein (HSIC) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Henry Schein (HSIC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ZacksLabCorp (LH) Misses Q1 Earnings Estimates
LabCorp (LH) delivered earnings and revenue surprises of -4.26% and 0.87%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
What's in Store for West Pharmaceutical (WST) in Q1 Earnings?
West Pharmaceutical's (WST) first-quarter 2023 results are likely to reflect strength in the Proprietary Products business. However, unfavorable currency movements might have hurt the top and bottom lines.
ZacksBDX vs. WST: Which Stock Is the Better Value Option?
BDX vs. WST: Which Stock Is the Better Value Option?
- Simply Wall St.
West Pharmaceutical Services' (NYSE:WST) investors will be pleased with their solid 296% return over the last five years
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But when you pick a company...
ZacksBDX or WST: Which Is the Better Value Stock Right Now?
BDX vs. WST: Which Stock Is the Better Value Option?
ZacksMerit Medical (MMSI) Down 0.7% Since Last Earnings Report: Can It Rebound?
Merit Medical (MMSI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Zacks
Reasons to Retain West Pharmaceutical (WST) in Your Portfolio
West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex concerns persist.
- Simply Wall St.
Why West Pharmaceutical Services, Inc. (NYSE:WST) Could Be Worth Watching
Today we're going to take a look at the well-established West Pharmaceutical Services, Inc. ( NYSE:WST ). The company's...
ZacksHSIC or WST: Which Is the Better Value Stock Right Now?
HSIC vs. WST: Which Stock Is the Better Value Option?
ZacksMMSI vs. WST: Which Stock Is the Better Value Option?
MMSI vs. WST: Which Stock Is the Better Value Option?
- Simply Wall St.
West Pharmaceutical Services Full Year 2022 Earnings: Revenues Beat Expectations, EPS Lags
West Pharmaceutical Services ( NYSE:WST ) Full Year 2022 Results Key Financial Results Revenue: US$2.89b (up 2.0% from...
ZacksWest Pharmaceutical (WST) Q4 Earnings Beat, Order Book Strong
West Pharmaceutical's (WST) fourth-quarter results reflect sustained growth in non-COVID-19 demand amid dismal overall performance.
ZacksWest Pharmaceutical Services (WST) Q4 Earnings and Revenues Beat Estimates
West Pharmaceutical (WST) delivered earnings and revenue surprises of 27.34% and 8.16%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
ZacksMedical Device Stocks' Q4 Earnings on Feb 16: WST, SWAV & More
Medical Device players are likely to have benefited from the reopening of economies and several efforts to combat macro headwinds. Let's see how WST, SWAV, AMN, ITGR and PACB are likely to fare this time.
- Zacks
Why West Pharmaceutical (WST) Might Surprise This Earnings Season
West Pharmaceutical (WST) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- Zacks
What's in Store for West Pharmaceutical (WST) in Q4 Earnings?
West Pharmaceutical's (WST) fourth-quarter results are likely to reflect strength in the Proprietary Products business. However, unfavorable currency movements are likely to hurt the top and the bottom lines.